Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

NCT06175065 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Interventions

DRUG: RLS-0071
DRUG: Placebo

Sponsor

ReAlta Life Sciences, Inc.